InMed Pharmaceuticals names CFO
Insight Weekly: US inflation soars; real estate faces slowdown; megadeals drive tech M&A
Commercial Banking: June 22nd Edition
Understanding Loss Given Default A Review of Three Approaches
Insight Weekly: Path to net-zero; US manufacturing momentum; China's lithium M&A frenzy
InMed Pharmaceuticals Inc. appointed Jeff Charpentier as CFO and corporate secretary.
Charpentier replaces outgoing CFO Terese Gieselman. He has previously served as CFO for Lifebank Corp., Inex Pharmaceuticals Corp. and Chromos Molecular Systems Inc.